Comp Set BALPHARMA ALPA× KREBSBIO× NATCAPSUQ× + VINEETLAB + NECLIFE + AAREYDRUGS + BIOFILCHEM + MANGALAM + LASA + MEDICAMEQ + MEDICO + ORTINGLOBE
In ₹ Crore except Per Share
Latest Annual
BALPHARMA
FY26
ALPA
FY26
KREBSBIO
FY26
NATCAPSUQ
FY26
Peer
Average
Valuation — at last close P/E 21.82× ◆ 7.78×— — 7.78× +180% P/B 1.67× ◆ 0.59×— 0.64× 0.61× +171% EV/EBITDA 9.13× -7.76× -64.63× ◆ -169.48×-80.62× +111% Market Cap ₹137 Cr ₹110 Cr ₹128 Cr ₹142 Cr ₹126 Cr +9% Growth Revenue CAGR 3Y 0.81% ◆ 4.61%-23.07% — -9.23% +109% Revenue CAGR 5Y ◆ 4.46%1.64% -15.07% — -6.71% +166% Net Income CAGR 3Y ◆ 34.12%5.92% — — 5.92% +476% Revenue YoY (latest Q) 34.53% 25.22% ◆ 38.94%7.76% 23.97% +44% Net Income YoY (latest Q) ◆ 445.66%-91.67% 12.12% -2.93% -27.49% +1721% Profitability EBITDA Margin ◆ 10.24%3.11% -22.97% -0.83% -6.90% +248% Net Income Margin 2.03% ◆ 14.19%-71.35% -13.17% -23.44% +109% Return on Common Equity 7.87% 8.39% ◆ 10.96%-7.51% 3.95% +99% Return on Capital Employed ◆ 17.17%0.66% -20.53% -6.12% -8.66% +298% Return on Assets 1.78% ◆ 6.46%-10.19% -5.85% -3.19% +156% Credit & Quality Total Debt/Equity 1.94× 0.01× ◆ -1.38×0.49× -0.29× +761% Interest Coverage 1.24× ◆ 4.64×-1.68× -1.71× 0.42× +198% Scale — latest FY Revenue / Total Income ₹312 Cr ₹106 Cr ₹23.7 Cr ₹187 Cr ₹106 Cr +195% Net Income ₹6.3 Cr ₹15 Cr −₹16.9 Cr −₹24.7 Cr −₹8.9 Cr +171% Total Assets ₹376 Cr ₹242 Cr ₹163 Cr ₹424 Cr ₹277 Cr +36% EPS ₹3.95 ₹6.71 ₹-7.85 ₹-23.84 ₹-8.33 +147% Book Value per Share ₹51.65 ₹88.53 ₹-75.49 ₹213.39 ₹75.48 -32%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › » Latest: FY26 · Consolidated CHART » ALPHA AI » COMP » FA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95% .
